Science

…big pharma… psychedelics

…the increasing interest that mainstream biotech firms are developing for psychedelic compounds.

While about 100 clinical trials focused on psychedelic compounds are chugging along in the regulatory pathway to examine the potential the drugs have to treat illnesses like depression and alcoholism, Big Pharma has largely taken a back seat in the growing industry, holding off on conducting trials or acquiring companies working with the compounds.

Original Article (Business Insider):
Compass Pathways’ new CEO says data from his firm’s upcoming clinical trial could finally persuade Big Pharma to jump into the psychedelics industry
Artwork Fair Use: Molino J, Lubiana Alves T, Ferreira-Camargo L, Croce M, Tanaka A, Buson F, Ribeiro P, Campos-Salazar A, Antonio E, Maizel A, Siratuti V, Costa C, Wlodarczyk S, de Souza Lima R, Mello F, Mayfield S, Carvalho J

Politics

Psilocybin… use…

Politics

…analysis… act

Science

What does kratom do?

Politics

The iron law

Science

…fentanyl overdoses…

Politics

…potential, if…

Science

Psychedelic… research…

Modern Culture

…to town

Politics

…Colorado ballot…

Politics

…peyote… all…

Science

…forage… grow…

Politics

…in [Oregon]…

Politics

Making mushrooms…

Politics

What does it mean…

Politics

…talks…

Science

…to define…

Spirituality

[Ergot…]

Anthropology

Hemp flowing…

Politics

…city on earth

Science

Shroom dosage…

Politics

Oregonians…

Spirituality

The future is fungi

Politics

…in Oregon

Psychology

MDMA… marriage…

Politics

…cannabis banking

Politics

…psilocybin… 

Psychology

…tripping solo

Spirituality

LSD… benefits…

Psychology

…salvinorin…

Anthropology

There will be oil

Anthropology

Cannabis goes green

Psychology

Home grow…

Psychology

…for macrodosing

Politics

First, it was weed…

Politics

Manufacturing…

Spirituality

…the Mushroom

Politics

Oregon psilocybin…